Current Opinion in Pulmonary Medicine

Article	Citations
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	45
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	38
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	31
The persistent problem of persistent air-leaks: approach to management	30
Home monitoring in asthma: towards digital twins	27
Bronchoscopic treatment of early-stage peripheral lung cancer	27
The role of PET in the management of sarcoidosis	26
Improving care in lung cancer surgery: a review of quality measures and evolving standards	24
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	23
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	20
Digital outcome measures in pulmonary clinical trials	18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	17
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	16
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	16
Considerations and clinical management of infections in sarcoidosis	15
Group 2 pulmonary hypertension: from diagnosis to treatment	15
Implementation of digital home monitoring and management of respiratory disease	15
Bronchoscopic diagnosis of peripheral lung lesions	15
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	15
Editorial introductions	14
Editorial introductions	14
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	14
Asthma in pregnancy: a review of recent literature	14
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	14

Lung transplant referral considerations for individuals with cystic fibrosis	14
The future of clinical trials in idiopathic pulmonary fibrosis	13
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	13
Progress for all: addressing disparities in sarcoidosis	13
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	12
Tobacco treatment in the setting of lung cancer screening	12
What causes cough in pulmonary fibrosis, and how should we treat it?	12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	12
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	12
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	12
Casting light on the many facets of sarcoidosis	12
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	12
Cystic fibrosis liver disease in the post-modulator era	12
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	11
Digital inhalers for asthma management	11
Imaging in peripheral bronchoscopy	11
Acute rejection post lung transplant	11
Home monitoring of coronavirus disease 2019 patients in different phases of disease	11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	11
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	10
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	10
Patterns of progression in non-IPF fibrotic interstitial lung disease	10
Effectiveness and safety of coronavirus disease 2019 vaccines	10
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	10
Editorial: Are we ready for prime time?	10
Novel insights in fibrotic pulmonary sarcoidosis	10
Exhaled breath analysis in interstitial lung disease	9
Epigenetics and aging: relevance for sleep medicine	9
Telerehabilitation in pulmonary diseases	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Infection control in cystic fibrosis: evolving perspectives and challenges	9
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	9
Multidisciplinary care in nonmalignant central airway obstruction	9
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	9
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
Adenotonsillectomy: the good, the bad and the unknown	8
Editorial: ‘What is your occupation?’: historical snippets	8
The association of preexisting severe asthma with COVID-19 outcomes	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	8
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	8
Ergonomics in bronchoscopy	8
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	8
Right ventricular assessment in pulmonary hypertension	8
The changing landscape of infections in the lung transplant recipient	8
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	8
Approach to the hospitalized patient with pulmonary arterial hypertension	7
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	7

Methamphetamine-associated pulmonary arterial hypertension	7
Prader–Willi syndrome: an update	7
Advancements in airway stents: a comprehensive update	7
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	7
Long-term safety, durability of response, cessation and switching of biologics	7
Military deployment-related respiratory problems: an update	7
Editorial introductions	7
Editorial introductions	6
Bronchoscopic lung volume reduction in emphysema: a review	6
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	6
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	6
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	6
Updates in the diagnosis and management of chronic thromboembolic disease	6
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	6
Pulmonary alveolar proteinosis – current and future therapeutical strategies	6
Artificial intelligence for the optimal management of community-acquired pneumonia	6
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	6
Recent advances predict a bright future for nebulizers	6
Editorial introductions	6
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	6
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	6
Health inequities in the modulator era	6
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	5
Editorial: The role of ageing in pulmonary disease	5
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	5
Bronchoscopic interventions for chronic bronchitis	5
Drug-resistant tuberculosis: advances in diagnosis and management	5
Lung infections due to emerging fungal pathogens	5
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	5
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	5
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	5
Role of biomarkers in lung nodule evaluation	5
Bacteriophages for bronchiectasis: treatment of the future?	5
Editorial introductions	5
What is new in mediastinal staging?	5
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”	5
Risk stratification of pulmonary embolism	5
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation	5
Editorial introductions	5
Interstitial lung disease following coronavirus disease 2019	5
Editorial introductions	5
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	5
Indwelling pleural catheters for benign pleural effusions: a concise review	5
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	5
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	5
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	4
COVID-19: vaccines, efficacy and effects on variants	4
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	4
Bedside to bench and back again-translational research in interventional pulmonology	4
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	4
Recent developments in occupational asthma	4
Editorial introduction	4
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	4
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	4
Pulmonary adverse events following immune checkpoint inhibitors	4
Editorial introductions	4
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	4
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	4
Anesthetic considerations in interventional pulmonology	4
Management of complicated parapneumonic effusions	4
Whole lung lavage: considerations from the anesthesiology perspective	4
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	4
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine	4
Environmental and occupational exposures in interstitial lung disease	4
SMART - is it practical in the United States?	3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	3
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	3
Glymphatic MRI techniques in sleep and neurodegenerative diseases	3
Pregnancy and fertility in people with cystic fibrosis following lung transplantation	3
Leveraging AI technology in sarcoidosis	3
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	3
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	3
Sex differences in sleep and sleep-disordered breathing	3
Lung transplantation: practical and important directions of care	3
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic	3
Update on the genetic basis of obstructive sleep apnoea – hype or hope?	3
Vitamin D deficiency in chronic obstructive pulmonary disease	3
The controversy over daylight saving time: evidence for and against	3
Ageing with Interstitial lung disease: preserving health and well being	3
Progress and challenges in fungal lung disease in cystic fibrosis	3

Diversity and disparity in the treatment and care of sarcoidosis	3
Keeping global focus on the many challenges of respiratory tract infections	3